Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss

American Heart Journal

Volumn 144, Issue 4, 2002, Pages 625-629

  Kostis, John B ^a   Wilson, Alan C ^a   Hooper, W Craig ^b   Harrison, Kathryn W ^b   Philipp, Claire S ^a   Appel, Lawrence J ^c   Espeland, Mark A ^d   Folmar, Steven ^e   Johnson, Karen C ^f  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM LOAD; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

EID: 0036790195     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(02)00132-1     Document Type: Article

References (19)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Hypertension 1995;25:305-13.
2. Elliott P, Stamler J, Nichols R, et al. Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. BMJ 1996;312:1249-53.
3. The Trials Of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels: results of the Trials Of Hypertension Prevention, Phase I. JAMA 1992;267:1213-20.
4. The Trials Of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials Of Hypertension Prevention, Phase II. Arch Intern Med 1997;157:657-67.
5. Whelton PK, Appel U, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998;279:839-46.
6. Luft FC, Miller JZ, Grim CE, et al. Salt sensitivity and resistance of blood pressure: age and race as factors in physiological responses. Hypertension 1991;17(1 Suppl):I-102-8.
7. Cusi D, Barlassina C, Azzani T, et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997;349:1353-7.
8. Svetkey LP, McKeown SP, Wilson AF. Heritability of salt sensitivity in black Americans. Hypertension 1996;28:854-8.
9. Abbud ZA, Wilson AC, Cosgrove NM, et al. Angiotensin-converting enzyme gene polymorphism in systemic hypertension. Am J Cardiol 1998;81:244-6.
10. Barley J, Blackwood A, Miller M, et al. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996;10:31-5.
11. Chiang FT, Lai ZP, Chern TH, et al. Lack of association of the angiotensin converting enzyme polymorphism with essential hypertension in a Chinese population. Am J Hypertens 1997;10:197-201.
12. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-4.
13. Appel U, Espeland M, Whelton PK, et al. Trial Of Nonpharmacologic intervention in the Elderly (TONE): design and rationale of a blood pressure control trial. Ann Epidemiol 1995;5:119-29.
14. Ewart CK. Social action theory for a public health psychology. Am Psychol 1991;46:931-46.
15. Kostis JB, Espeland MA, Appel L, et al. Does withdrawal of antihypertensive therapy medication increase the risk of cardiovascular events: results from the Trial Of Nonpharmacologic interventions in the Elderly (TONE). Am J Cardiol 1998;82:1501-8.
16. Rigat B, Hubert C, Corvol P, et al. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucleic Acids Res 1992;20:1433.
17. Espeland MA, Whelton PK, Kostis JB, et al. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. Arch Fam Med 1999;8:228-36.
18. Hunt SC, Cook NR, Oberman A, et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials Of Hypertension Prevention, phase II. Hypertension 1998;32:393-401.
19. Zhang R, Reisin E. Obesity-hypertension: the effects on cardiovascular and renal systems. Am J Hypertens 2000;13:1308-14.